The results showed that CRC patients with high CXCL3 (p = 0.0015), ELF5 (p = 0.0094), and TIMP1 (p = 0.0017) expression had a significantly shorter OS (Figures 8(a)–8(d)), whereas, for patients with low PHLPP2 expression, a longer OS was observed (p = 0.0091). This evidence concerns the gene CXCL3 and colorectal carcinoma.